The Vimentin-Targeting Drug ALD-R491 Partially Reverts the Epithelial-to-Mesenchymal Transition and Vimentin Interactome of Lung Cancer Cells
Marieke Rosier(Karolinska Institutet), Annica K. B. Gad(Uppsala University)
Cited by 1
Related Papers
Vimentin Diversity in Health and Disease
|Cells|2018|272
Metastasising Fibroblasts Show an HDAC6-Dependent Increase in Migration Speed and Loss of Directionality Linked to Major Changes in the Vimentin Interactome
|International Journal of Molecular Sciences|2022|13
The Vimentin-Targeting Drug ALD-R491 Partially Reverts the Epithelial-to-Mesenchymal Transition and Vimentin Interactome of Lung Cancer Cells
|Preprints.org|2024|2
Regulation of cellular contractile force, shape and migration of fibroblasts by oncogenes and Histone deacetylase 6
|Frontiers in Molecular Biosciences|2023|0